kadsurenone has been researched along with thromboxane b2 in 2 studies
| Studies (kadsurenone) | Trials (kadsurenone) | Recent Studies (post-2010) (kadsurenone) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 51 | 0 | 3 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CC; Huang, TF; Huang, YL; Teng, CM; Yu, SM | 1 |
| Felsen, D; Freund, RM; Vaughan, ED; Weisman, SM | 1 |
2 other study(ies) available for kadsurenone and thromboxane b2
| Article | Year |
|---|---|
Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone.
Topics: Animals; Benzofurans; Blood Platelets; Calcium; Collagen; In Vitro Techniques; Lignans; Molecular Structure; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Rabbits; Stereoisomerism; Thrombin; Thromboxane B2 | 1990 |
Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Benzofurans; Dinoprostone; Kidney; Lignans; Male; Peptides; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Prostaglandins E; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thromboxane B2; Triazolam; Ureteral Obstruction | 1988 |